Invivyd Announces Continued Neutralizing Activity of PEMGARDA™ ( pemivibart ) Against Dominant SARS-CoV-2 Variants KP.3.1.1 and LB.1, and Other Variants of Interest

2 weeks ago

WALTHAM, Mass., Sept. 03, 2024 ( GLOBE NEWSWIRE ) -- Invivyd, Inc. ( Nasdaq: IVVD ) , a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced that new pseudovirus in vitro neutralization data show continued neutralizing activity of ...

Ticker	Sentiment	Impact
IVVD	Neutral	20 %